Vectura Group plc is a product development company focused on the development of a range of inhaled therapies, principally for the treatment of respiratory diseases. Our goal is to improve patients’ lives and generate value for our stakeholders.
Press releases
06 August 2010Vectura and GlaxoSmithKline sign agreement to license some of Vectura’s dry powder drug formulation patents
03 August 2010Interim Management Statement
07 June 2010Vectura Group plc - Preliminary Results
Latest press releases
Next events
21 September 2010Credit Suisse US Bus Tour, London
22 September 2010
Annual General Meeting, London
Investor Calendar
